Pentax updates scope reprocessing instructions, EndoChoice receives price target of $19.67 & more – 3 GI company key notes

Here are three recent news updates on key gastroenterology and endoscopy companies.

Advertisement

Pentax Medical updated reprocessing instructions for its ED-3490TK video duodenoscope.

EndoChoice Holdings stock has received an average 12-month consensus price target of $19.67.

Deutsche Bank Securities raised Allergan’s price target to $339.

More articles on GI/endoscopy:
GI physician leader to know: Dr. Shivagi Kothari of University of Rochester Medical Center
EndoChoice receives average price target of $19.67: 4 points
URMC GI experts to host advanced endoscopy course for nurses, mid-level providers: 4 notes

Advertisement

Next Up in GI & Endoscopy

  • The MUSC Shawn Jenkins Children’s Hospital in Charleston, S.C., has launched the MUSC Advanced Pediatric Endoscopy Program and Pancreas Center. …

  • For GI clinics and ASCs, accurate coding and documentation are critical to protecting reimbursement, reducing denials and withstanding payer audits. …

Advertisement

Comments are closed.